485 ROUTE 1 SOUTH, ISELIN, NJ
Market cap: $89.3M (12/18/2025)
Price: $2.01
Reports Financial Results for Fiscal Year 2025
Re-Submits Biologics License Application for ONS-5010
Provides Update on Type A Meeting with FDA
Changes in Board, Management or Compensation
Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
Earnings Release
News, Material Contracts
Other Events
FY 2025
Q3
Q1
Amended Annual Report
FY 2024
Q2
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership